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Abstract
Background: Shigatoxigenic E. coli are a global and emerging health concern. Shiga toxin, Stx, is encoded on the
genome of temperate, lambdoid Stx phages. Genes essential for phage maintenance and replication are encoded
on approximately 50% of the genome, while most of the remaining genes are of unknown function nor is it
known if these annotated hypothetical genes are even expressed. It is hypothesized that many of the latter have
been maintained due to positive selection pressure, and that some, expressed in the lysogen host, have a role in
pathogenicity. This study used Change Mediated Antigen Technology (CMAT)™ and 2D-PAGE, in combination with
RT-qPCR, to identify Stx phage genes that are expressed in E. coli during the lysogenic cycle.
Results: Lysogen cultures propagated for 5-6 hours produced a high cell density with a low proportion of
spontaneous prophage induction events. The expression of 26 phage genes was detected in these cultures by
differential 2D-PAGE of expressed proteins and CMAT. Detailed analyses of 10 of these genes revealed that three
were unequivocally expressed in the lysogen, two expressed from a known lysogenic cycle promoter and one
uncoupled from the phage regulatory network.
Conclusion: Propagation of a lysogen culture in which no cells at all are undergoing spontaneous lysis is
impossible. To overcome this, RT-qPCR was used to determine gene expression profiles associated with the growth
phase of lysogens. This enabled the definitive identification of three lambdoid Stx phage genes that are expressed
in the lysogen and seven that are expressed during lysis. Conservation of these genes in this phage genome, and
other Stx phages where they have been identified as present, indicates their importance in the phage/lysogen life
cycle, with possible implications for the biology and pathogenicity of the bacterial host.
Background
Shigatoxigenic Escherichia coli (STEC) cause disease in
humans following colonisation of the intestinal tract [1].
These infections are often serious, presenting with
severe diarrhoea accompanied by haemorrhagic colitis.
Downstream sequelae such as haemolytic uraemic syn-
drome (HUS) and thrombotic thrombocytopenic pur-
pura (TTP) can be fatal [2,3].
The principle defining virulence determinant of all
STEC strains is the production of Shiga toxin (Stx), also
known as verocytotoxin (VT) or Shiga-like toxin (SLT)
(1), of which there are two distinct forms, Stx1 and Stx2
[4]. Two variants of Stx1 have been identified [5,6],
whilst Stx2 is heterogeneous, with some variants more
frequently associated with serious STEC outbreaks [1,7].
The stx genes are carried by temperate lambdoid bacter-
iophages, which enter eithert h el y t i co rt h el y s o g e n i c
pathways upon infection of a bacterial cell [8-10]. Any
bacteriophage encoding Stx is termed an Stx phage, and
there is much genotypic and phenotypic diversity within
this loosely-defined group [11]. Integrated Stx phages
may exist in the bacterial chromosome as inducible pro-
phages, or their residence within a host cell may facili-
tate recombination events leading to the loss of
prophage sequences, resulting in uninducible, remnant
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stx genes are located with genes involved in the lytic
cycle; hence Shiga toxin expression occurs when Stx
phages are induced into this pathway [11,13].
Stx phages possess genomes that are generally ~50%
larger than that of the first described lambdoid phage, l
itself, and ~74% of Stx phage genes have not been defi-
nitively assigned a function [11]. Genes that are essential
for the Stx phage lifestyle are carried on approximately
30 kb of DNA [14], whilst the entire genome is ca 60 kb
in size in most cases [11,15,16]. The impact of Stx
prophage carriage on the pathogenicity profile or biol-
ogy of the host, beyond conferring the ability to produce
Shiga toxin, has remained largely unexplored and it can
be suggested that the accessory genome of Stx phages is
likely to encode functions for which there has been
positive selection [11].
In this paper, we describe the use of proteomic-based
protein profile comparisons and Change Mediated Anti-
gen Technology™ (CMAT) (Oragenics Inc.) [17] to
identify Stx phage genes that are expressed during the
lysogenic pathway. An E. coli lysogen of F24B::Kan, in
which a kanamycin-resistance cassette interrupts the
stx2A gene [18] of a phage isolated from an E. coli
O157:H7 disease outbreak strain, was subjected to both
CMAT and two dimensional polyacrylamide gel electro-
phoresis (2D-PAGE) analyses of the expressed pro-
teome. The F24B ::Kan genome is 57.6 kb in size and is
identical in all aspects to its wild-type parental phage
other than the stxA gene interruption [14,18]. The
majority of genes and coding sequences (CDS) carried
by F24B are simply annotated as hypothetical [GenBank:
HM_208303]. Bacteriophages tightly regulate expression
of their genes involved in maintenance of lysogeny ver-
sus replication of viral progeny, and the differentiation
of gene expression associated with each state needed to
be carefully determined in order to definitively associate
expressed proteins and their genes with either the tem-
perate or the lytic cycle.
Results
The rate of spontaneous lysis in an E. coli MC1061(F24B)
culture at different stages of growth
Spontaneous induction, defined as the induction of pro-
phages from lysogens in the absence of an applied sti-
mulus [19], occurs constantly in a proportion of the
lysogen population in any culture, and this could ser-
iously interfere with the differentiation of gene expres-
sion between lytic and lysogenic states. In this study, it
was necessary to determine culture conditions under
which the number of spontaneous induction events was
low whilst the cell density was high, enabling the consis-
tent harvesting of sufficient amounts of cell-associated
protein for downstream analyses. Lysogen cultures were
sampled at hourly intervals beginning two hours post
inoculation, and the c.f.u. ml
-1 and p.f.u. ml
-1 deter-
mined. The lowest ratio of infective phages to cells,
1:50, occurred at both 2 h and 3 h of lysogen growth.
However the c.f.u. ml
-1 during these times was relatively
low; OD600 = 0.184 (± 0.003) and OD600 = 0.651 (±
0.008), respectively. The ratio of phage to host cells
increased sharply after 4 h of growth, before dropping
a f t e r5ht o1 : 3 3( O D 6 0 0=1 . 1 9 2[ ±0 . 0 1 1 ] ) .T h er a t i o
of phage to cells in the culture remained stable at 1:33
through to 6 hours of growth. Lysogen growth condi-
tions were therefore standardised for MC1061 (F24B)a t
5-6 hours when the cells were grown to an OD600 of
1.2-1.3.
Phage-encoded, lysogen-culture gene expression
identified by CMAT
A total of 13,519 clones were subjected to CMAT pri-
mary screening, and taking efficiency of the library into
account, this equates to a 3.3x coverage of the phage
genome. Of these, 330 were identified by the lysogen-
specific antiserum and chosen for further analyses and
secondary screening. After two rounds of secondary
screening, 250 clones were removed from the study and
PCR analysis of the remaining 80 clones demonstrated
that 46 possessed vector DNA only. The remaining 34
recombinant transformants produced a peptide recog-
nised by antibodies in the lysogen specific antiserum.
The cloned inserts were sequenced, and the DNA
sequences translated in all six possible reading frames.
Twenty-three of the clones possessed sequences from
twenty different F24B C D S( T a b l e1 ,F i g u r e1 ) .T h e
remaining eleven clones did not align with any F24B
-encoded CDS, although six did possess non-coding
regions of the phage genome. The other five clones con-
tained plasmid DNA only.
Phage-encoded, lysogen-culture gene expression
identified by 2D-PAGE
Reproducible sets of gels from 2D-PAGE analyses were
obtained through the utilisation of IPG strips in the pH
ranges of 3.5-5.6 and 5.3-6.5. The optimal protein con-
centration loaded on the gels was found to be 200 μgo f
total cellular protein from crude cell lysates. A total of
42 protein spots were found only in the lysogen gel sets
(data not shown); these were excised from the gels and
analysed by MALDI-TOF. Twenty-four of these spots
(Figure 2) contained enough protein for the generation
of mass spectral data. When these spectra were searched
against the University of Liverpool MASCOT database,
which included all of the F24B genome predicted pro-
teins, six samples matched predicted phage proteins (P1
to P6, Table 2, Figure 1). The remaining 20 spots were
identified as E. coli proteins (Table 2); these are
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further here.
Analyses of gene expression patterns
Generally, lambdoid phage regulatory circuits tightly
control the expression of genes, yet some of the genes
identified in the CMAT library and the 2D-PAGE ana-
lyses above were phage genes whose expression should
be linked to prophage induction (Figure 1) and not the
stable prophage state, e.g. the gene encoding the tail
spike protein. It was assumed that gene expression nor-
m a l l yl i n k e dt ot h el y t i cr e p l i c a t i o nc y c l em u s tb ea ta
very high level in a small subset of the cells and that
lysogen-restricted gene expression patterns of these
genes might be very low, especially as neither CMAT
nor 2D-PAGE identified the expression of repressor, the
product of the cI gene, in the lysogen culture. Therefore
it was essential to devise a method that would deter-
mine whether phage genes were being expressed by the
majority of the stable lysogen population, or the small
Table 1 CDS identified by CMAT and location on the
F24B genome
Clone Alignment to F24B
genome
Aligned CDS Possible
gene
CM1 39370-39772 38090-40027 tspS
CM2 +
CM14
17489-18104 17559-18086 dam
CM3 2523-2185 a: 2378-2286
b: 2507-2379
CM4 3025-2375 a: 2545-2375
b: 2812-2711
c: 2911-2840
CM5 54385-53866 53693-53866
CM6 53690-53235 53482-53297
CM7 +
CM13
55160-55667 49148-57571
CM8 38754-39248 38460-38954
CM9 2542-2940 2248-2646
CM10 35049-34598 33695-34702
CM11 +
CM12
39573-40016 40189-39355
CM15 40137-40506 40345-40626
CM16 38041-37623 38000-37698
CM17 52465-52147 52191-52514
CM18 45227-45877 44818-45552 lom
CM19 45610-46100 45981-46382
CM20 4098-3676 4333-4052
CM21 39305-39919 39405-39650
CM22 39875-40526 39909-40298
CM23 45713-46232 a: 45784-
45921
b: 46072-
46239
Figure 1 Schematic representation of the F24B genome.
Squares symbolise the locations of the CMAT and PAGE CDS
identified as well as some of the essential genes involved in the life
cycle of the phage. - represents 5 kb. For further details on the
gene identities see Tables 1 & 2.
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tion events. A strategy involving qPCR was developed to
provide this important information, and a variety of
genes were chosen as controls for this study (Additional
file 1: Table S1, Figure 1). Calibration curves for quanti-
tation and comparison of the qRT-PCR data were pro-
duced for every set of primers used; R
2 values from
linear regression analyses of these standards ranged
from 0.990 to 0.999 with slopes ranging between -3.72
and -3.10 (Additional file 1: Table S1).
The data from the qPCR assay were analysed by com-
paring the shape of the expression data for any given
gene from a lysogen culture throughout the prophage
induction process where time 0 is the point of norfloxa-
cin (inducer) addition (Figure 3). Lysogen-restricted
gene expression should be negatively affected after
induction (Figure 3A, CI), and if expression is actually
linked to the small proportion of cells undergoing spon-
taneous induction, then the expression levels should rise
during the induction process. This is indeed the case as
expected for Q, Cro, Capsid & Terminase, which display
a significant increase after 50 min of recovery, Figure 3;
Additional file 2: Table S2).
Four genes identified by 2D-PAGE, P1, P4, P5 and P6,
visibly follow the same expression pattern as the genes
expressed during the lytic cycle and accordingly the
increase in gene copy number is significant (p-value <
0.05) after 50 or 60 min of recovery from exposure to
norfloxacin (Figure 3; Additional file 2: Table S2). P3
and P2 appear to have a similar pattern to cI,i . e .t h e i r
levels of expression in the lysogen are higher than the
levels after induction; however the ANOVA analysis did
not identify these differences as significant, probably due
to the high variability amongst the replicates. Of the five
CDS identified by CMAT, which were subsequently
selected for expression analysis based upon either their
putative function or location within the phage genome,
four had expression patterns linked to the lytic cycle.
CM18 was shown by qPCR to be strongly expressed in
lysogen cultures, but when the cells are induced, high
Figure 2 2D-PAGE images of total cell protein from MC1061/F24B::Kan.I E Fo np Hr a n g e4 - 7( A ,C ) ,5 . 3 - 6 . 5( B )a n d3 - 5 . 6( D ) .A r r o w s
represent proteins identified as phage encoded; circles represent proteins identified as encoded by E. coli, but not present on corresponding
naïve MC1061 gels (data not shown).
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P♯ Gene name Access No. pI/
MW
(Da)
Description Sequence
a
Coverage
(%)
MASCOT
b
Score
Peptides
c
matches
Estimated
pI/MW (Da)
MASCOT
Database
Identified in
1 P1 5.28/
33860
Identical to hypothetical
protein p78 from 933 W
d
32 63* 6 5.50/40000 1
2 P2 5.27/
17096
Similar to hypothetical protein
p23 from 933 W
42 39 5 5.00/15000 1
3 P3 5.09/
13472
Similar to hypothetical protein
p24 from 933 W
33 55 3 5.6/8000 1
4 P4 5.14/
25800
Identical to exo of 933 W 29 52 5 5.5/40000 1
5 P5 5.29/
7336
Not known homologue 83 41 2 7.00/7000 1
6 P6 5.22/
13628
Identical to hypothetical
protein Stx2Ip064
e
38 30 4 7.00/10000 1
7 nanA2 Q6KD26 5.77/
34077
N-acetylneuraminate lyse 2 21 47 4 5.3/35000 2
8 gadB CAQ31981 5.29/
52634
Glutamate decarboxylase beta 23 57 7 5.3/35000 2
9 sodB P0AGD5 5.58/
21121
Superoxide dismutase [Fe] 40 53 6 4.00/100000 2
10 napA AAC75266 8.23/
92983
Nitrate reductase 14 49 7 5.5/100000 2
11 tig AAA62791 4.73/
47994
Trigger factor 24 58* 7 3.5/6000 2
12 UTI89_C3021 Q1R837 4.70/
6971
Hypothetical protein 70 42 2 5.5/7000 2
13 2FPKA ZP_04873224 5.24/
32497
6-phosphofructokinase 23 46 5 5.3/50000 2
14 gcpE S23058 5.87/
40658
1-hydroxy-2-methyl-2-(E)-
butenyl 4-diphosphate
synthase
16 38 4 5.5/80000 2
15 aceE P0AFG9 5.46/
99475
Pyruvate dehydrogenase E1
component
10 60* 7 5.4/100000 2
16 bfpK Q9S141 7.63/
18294
BfpK 54 49 3 6.4/25000 2
17 ychN P0AB53 5.02/
12685
ychN 46 38 2 5.3/100000 2
18 UTI89_C1147 Q1RDD 5.57/
24945
Hypothetical protein 15 38 4 5.7/30000 2
19 ompC Q9RH85 4.55/
40474
Outer membrane protein 18 44 4 5.5/40000 2
20 ECs1247 G90784 4.74/
25144
Hypothetical protein 26 39 5 6.5/35000 2
21 UTI89_C2748 Q1R8V6 10.19/
10724
Hypothetical protein 44 50 4 6.4/8000 2
22 nirB E86001 5.79/
93112
Nitrate reductase (NAD(P)H)
Subunit
10 53 8 5.3/100000 2
23 yagP CAQ30761 5.65/
15401
yagP protein 36 43 3 5.3/10000 2
24 rhsF Q47284 5.69/
23342
RhsF 18 42 4 5.69/8000 2
Table represents matches to E. coli proteins in the MASCOT database and matches to F24B proteins in the University of Liverpool local MASCOT database
a percentage of sequence of the matched protein that is covered by the experimental MS.
b logarithm of the probability that the match between the experimental data and a protein sequence in the database is a random event.
c number of peptides that match the protein in the database
d 933 W is an Stx2 phage described by Plunkett et al. [16].
e Stx2 is an Stx2 phage described by Sato et al. [20].
*represents significant matches (p-value < 0.05)
1 University of Liverpool local MASCOT database; 2 general MASCOT database
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sion of this gene has been uncoupled from the phage
regulatory circuits. The outcome of one-way ANOVA
analysis to determine the impact of prophage induction
on gene expression was found to be significant in 11
cases (p-value < 0.05): cI, cro, terminase, capsid, Q,
CM1, CM2, CM5, CM7, P1 and P5. The other 7 genes
studied did not present significant changes in expres-
sion: P2, P3, P4, P6, CM18, 16S, and gyraseB. The full
s e to fp - v a l u e sf o rt h ed a t ai nF i g u r e3a r ep r e s e n t e di n
Additional file 2: Table S2.
Discussion
Temperate phages, maintained as prophages in their
lysogens, have been the subject of speculation concern-
ing their benefit to the host: selective advantage,
increased virulence, and other traits with varying
degrees of direct and/or indirect impact on the host
have been identified [11,21-27]. The challenge in this
area has been how to identify phage-encoded genes that
directly affect their lysogen, because many/most phage
genes are annotated as encoding hypothetical proteins.
In addition, there will always be a small background
population undergoing spontaneous induction in the
absence of discernible stimuli [19], potentially confound-
ing the identification of lysogen-restricted prophage
gene expression. In a specific E. coli lysogen of Stx2-
phage 933W, a phage very closely related to F24B,t h e
spontaneous induction rate was calculated as 0.014%
[28], which means that in a lysogen culture fourteen
cells per 100,000 are undergoing prophage induction.
Other recent work was demonstrated that various
induction agents and growth conditions differentially
effects induction in a prophage-dependent manner [29].
Assuming a burst size similar to that of bacteriophage
Lambda (170 ± 10 virions cell
-1) [27], a significant
amount of phage structural protein production can
occur in an uninduced lysogen culture.
In order to mitigate this effect, the growth phase at
which the ratio of lysogens to free phage was high (two
to three hours post inoculation) was targeted. However,
the cell density at this point was very low and 5-6 hours
was chosen as the standardised incubation time as a
compromise. In this study, 26 genes from the bacter-
iophage F24B were identified by either CMAT or 2D-
PAGE as being expressed in E. coli lysogen culture. No
genes were identified by both CMAT and 2D-PAGE
methods, perhaps due in part to the low absolute num-
ber of F24B genes identified by the latter approach.
However, the level of redundancy in the genes identified
by the CMAT clones was lower than expected, given
the number of clones screened and the calculated phage
genome coverage; however, putative positive clones were
selected conservatively in an attempt to limit the num-
ber of false positives. Additionally, CMAT-based identi-
fication may also introduce bias into library screening
due to differences in protein immunogenicity and anti-
genicity. It is important to note that the best charac-
terised lysogen-restricted gene, cI (encoding lambdoid
phage repressor), was not identified using either CMAT
Figure 3 Graph depicting gene expression profiles before and following norfloxacin induction. Panel A: Control Genes. CI, marker gene
for lysogeny-restricted expression; Cro and Q, marker genes for early induction response; Ter and Cap, marker genes for late gene expression;
GyrB and 16S, marker genes for the cellular response. Panel B: Expression profiles of the prophage genes identified by CMAT. Panel C:
Expression profiles of the genes identified by 2D-PAGE analyses of the lysogen. The Y axis represents gene copy number per 300 ng of RNA; the
X axis represents time (min). Time -60 refers to the samples taken before induction and represents the lysogen population, Time 0 represents
samples taken at the beginning of the recovery time, Time 10, 10 min after recovery, etc. The experiment was run using biological replicates, but
due to the asynchronicity of induction across these experiments the data from a representative single biological replicate are shown.
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tive. Nevertheless, the paucity of information on lyso-
gen-restricted gene expression is such that these data
represent a significant step forward in our understand-
ing of phage/host interactions and lysogen biology.
Of the 26 phage genes identified in this study, Tsp,
encoding the characterised tail spike protein of F24B
[30,31] was a known structural protein and therefore
n o te x p e c t e dt ob ee x p r e s s e db yas t a b l el y s o g e n
(Tables 1 &3), while the expression profiles of the
other 25 proteins were unknown. Therefore the result-
ing challenge was to identify the fraction of the culture
(lysogens or cells undergoing lysis) that were responsi-
ble for expression of these 26 phage genes as well as
determining testable hypotheses to assign function to
the identified gene products. Five genes identified dur-
ing the CMAT screening were chosen for gene expres-
sion profiling due to their genome location, potential
function or degree of conservation across a range of
phages (Table 3). The CDS CM18 encodes a Lom
orthologue, which was expected to be expressed in the
lysogen as the lambda lom gene is associated with the
alteration of the lysogen’s pathogenic profile after loca-
tion of Lom in the outer membrane [32-34]. However,
expression of lom in the F24B lysogen unexpectedly
appears to be uncoupled from the phage regulatory
pathways, because it is expressed at similar levels in an
infected cell regardless of whether that cell exists as a
stable lysogen or is undergoing prophage induction.
The CDS CM2 encodes a putative Dam methyltransfer-
ase. Bacterial-encoded Dam methyltransferase has been
shown to be essential for maintenance of lysogeny in E.
coli infected with Stx-phage 933 W [35]. The expres-
sion pattern of the F24B-encoded Dam methyltransfer-
ase could indicate that it is fulfilling a similar role, or
supplementing the function of the host-encoded Dam
methylase in lysogens infected with this phage. The
functions of CM5 and CM7 are unknown. CM7 is an
ORF of 8 kb, and as the amount of DNA that can be
packaged by a phage is limited, such a large gene is
likely to be conserved only if it confers an advantage to
the phage or its lysogen; it may be significant that this
large gene is associated with several other phages
(Table 3). CM5 is a small CDS located on the comple-
mentary strand to the one encoding CM7, in a region
with few other CDS, though it is directly upstream of
another CMAT-identified CDS, CM6. The data (Figure
3) indicate that the expression of these 3 genes is
linked to prophage induction, a surprising outcome as
CM7 does not appear to be a phage structural gene,
has been indicated by bioinformatic analyses (data not
shown) to be a probable outer membrane protein, and
is downstream of CM18, whose regulation is uncoupled
from expression of the late genes.
The qPCR expression profile for the phage genes iden-
tified as being expressed in the lysogen by 2D-PAGE,
P1, P2, P3, P4, P5 and P6, indicated that only the
expression of P2 and P3 were restricted to lysogen cul-
tures with a stable prophage. The genes for both P2 and
P3 lie downstream of the cI gene. However, their
expression levels are one and five orders of magnitude
greater, respectively, than the expression levels of cI,t h e
lambdoid phage repressor gene. It is known that in
Lambda phage, the cI gene transcript is leaderless, pos-
sessing no ribosome binding site for initiation of transla-
tion, with transcription and translation beginning at the
AUG start codon [36]. If this causes the 5’ end of the
transcript to be less stable and more easily subject to
degradation, the higher level of P3 transcript could sim-
ply be due to possession of a longer half life than those
genes at the 5’ end of the transcript.
The genes encoding P2 and P3 are conserved in many
other phages (Table 3). They have no bioinformatically
identifiable promoters of their own, so are likely to be
driven by pRM or pRE like cI (see [37] for a cogent
review of the related lambda phage), but differences in
the levels of transcription between these 3 genes implies
that there is still more to discover about the right opera-
tor region of this phage. The proteins P1, P4, P5 and P6
all exhibit gene expression profiles that suggest they are
expressed following prophage induction. These genes
are scattered across the phage genome (Figure 1) and
are shared by various phages (Table 3). The protein P4
appears to be part of the lambda Red recombinase sys-
tem [38-40] and the data presented here suggest that
this is most active upon prophage induction. This could
be relevant to the mechanisms that underpin diversifica-
tion, evolution and production of new phages by lyso-
gens carrying an inducible prophage along with one or
more inducible or remnant prophages [11,41,42]. The
proteins P1, P5 and P6 are scattered across the genome
on the strand typically associated with expression of
genes linked to lysogenic infection (e.g. cIII, N, cI). Two
genes encoding proteins P1, P5 and P6 are found in
other phages, but have no known function.
In summary, genome sequencing of prophages and
bacteriophages has identified that these viral elements
encode higher numbers of hypothetical genes than those
to which we can currently assign a function. These
genes are often conserved across many bacteriophages,
but do not appear to encode structural proteins. For
these genes to remain present in the phage genome,
especially considering the fluidity of the genetic compo-
sition of lambdoid phages [43], they must surely provide
an important function in either the phage life cycle or
that of the lysogen itself. In attempting to identify
prophage genes whose expression was restricted to the
stable prophage state, our goal was to identify prophage
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Gene Other Stx phages carrying the proteins in the study (identity) Accession
number
Other phages Accession
number
CM1 Stx2 converting phage II (99%) YP_003828920.1
phage VT2-Sakai (99%) NP_050557.1
phage 933 W (99%) NP_049519.1
Stx1 converting phage (99%) YP_003848832
phage BP-933 W (99%) YP_003848832.1
phage VT2phi_272 (99%) ADU03741.1
phage Min27(100%) ADU03741
CM2 Stx2 converting phage II (100%) BAC78116
phage VT2-Sakai (100%) NP_050531.1
phage Min27 (100%) YP_001648926
phage HK97 (99%) AAF31137
phage Lahn2 (99%) CAJ26400
phage Lahn3 (98%) CAC95062.1
phage 2851 (99%) CAQ82016
phage CP-1639(99%) CAC83142
prophage CP-933 V(99%) AAG57233
Phage Nil2 (99%)(99%) CAC95095
Stx1 converting phage (99%) YP_003848889.1
Phage CP-1639 (99%) CAC83142.1
Phage YYZ-2088 (99%) YP_002274170.1
Stx2-converting phage 1717 (99%) YP_002274244.1
CM5 phage Min27 (100%) YP_001648966.1
Stx2 converting phage II(100%) YP_00388933.1
Stx2 converting phage I(100%) NP_612929.1
phage VT2-Sakai (100%) NP_050570.1
phage 933 W (100%) NP_049532.1
phage VT2phi_272 (100%) ADU03756
CM7 phage VT2-Sakai (99%) NP_050570
Stx1 converting phage (99%) BAC77866.1
Phage VT2phi_272 (97%) ADU03756.1
Phage 933 W (97%) NP_049532.1
Stx2 converting phage I (97%) NP_612929.1
Stx2 converting phage II(97%) BAC78032.1
Phage BP-933 W (97%) AAG55616.1
Stx2 converting phage 86 (91%) YP_794082.1
Phage Min27 (97%) YP_001648966.1
CM18 phage VT2-Sakai (100%) NP_050564.1
Stx1 converting phage (100%) YP_003848839.1
Phage 933 W (100%) NP_049526.1
Stx2 converting phage I (100%) ZP_02785836.1
Stx2 converting phage II (100%) YP_003828926.1
Phage BP-933 W (100%) NP_286999.1
Stx2 converting phage 86 (97%) YP_794076.1
Phage Min27 (100%) YP_001648959.1
P1 Stx2 converting phage II (99%) YP_003828937.1 Phage phiV10 (78%) YP_512303.1
Stx2 converting phage I (99%) NP_612952.1
Phage 933 W (99%) NP_049538.1
Phage BP-933 W (99%) AAG55619.1
phage VT2-Sakai (99%) NP_050575.1
Phage Min27 (96%) YP_001648901.1
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Page 8 of 14genes that were candidates for influencing the fitness of
the bacterial host. However, the study was hampered by
the fact that lysogen-restricted gene expression can be
at very low levels, and phage genes associated with
phage replication are expressed at very high levels.
Conclusions
Two different experimental strategies were employed to
identify prophage genes expressed by their lysogen, and
it is interesting to note that lysogen-specific antibody
recognition of a peptide expression library and differen-
tial 2D-PAGE with subsequent protein identification by
peptide mass spectrometry, did not identify the same
genes or proteins. The failure of both to identify
expression of the cI gene encoding the phage repressor
w a ss h o w nb yR T - q P C Rt ob ed u et ot h ev e r yl o w
expression levels peculiar to this phage gene (Figure 4);
the CI protein is also very susceptible to autocatalysis
and therefore elusive. Both CMAT and 2D PAGE identi-
fied some phage genes that were associated with lytic
induction, and the qPCR strategy was useful for discri-
minating low level expression in stable lysogens from
high-level gene expression in the minority of lysogens
that were undergoing spontaneous induction. Improving
our understanding of the STEC disease process is ever
more urgent in light of the recent emergence of a new
Shiga-toxin producing E. coli pathotype [44], and deter-
mining the function and expression patterns of the
Table 3 Distribution of the proteins identified by CMAT and 2D-PAGE across phage genomes (Continued)
Stx2-converting phage 86 (96%) YP_794094.1
Phage BP-4795 (96%) YP_001449244.1
phage CP-1639 (74%) CAC83133.1
P2 Stx2 converting phage I (100%) NP_612997.1 Salmonella enteric YP_002455860.1
Phage 933 W (100%) NP_049484.1 bacteriophage SE1 (86%)
Phage BP-933 W (100%) AAG55573.1 Salmonella phage ST160 (86%) YP_004123782.1
Phage Min27 (100%) ABY49878.1
Stx2-converting phage 86 (100%) YP_794109.1
P3 Stx2 converting phage I (100%) NP_612995.1
Phage 933 W (100%) NP_049483.1
Stx2-converting phage 86 (100%) YP_794108.1
Phage Min27 (100%) YP_001648915.1
Phage BP-933 W (100%) AAG55572.1
P4 Phage 933 W (100%) NP_049473.1 Phage lambda (98%) NP_040616.1
Phage BP-933 W (100%) NP_286952.1
Prophage CP-933 V (100%) NP_288695.1
Stx2 converting phage I (100%) NP_612980.1
Phage VT1-Sakai (100%) BAB19617.1
Phage YYZ-2008 (99%) YP_002274150.1
Stx2-converting phage 1717 (98%) YP_002274221.1
prophage CP-933 K (98%) YP_003500773.1
phage BP-4795 (98%) YP_001449249.1
phage Min27 (99%) YP_001648905.1
P5 Stx2 converting phage I (100%) NP_613032.1
Phage 933 W (100%) NP_049503.1
Stx2 converting phage II (100%) BAC78139.1
Stx2-converting phage 1717 (98%) YP_002274255.1
phage 2851 (98%) CAE53952.1
Phage BP-4795 (97%) YP_0014419282.1
P6 Stx2 converting phage I (99%) NP_612943.1
Stx2 converting phage II (99%) BAC78046.1
phage VT2phi_272 (99%) ADU03756.1
phage Min27 (99%) YP_001648966.1
phage VT2-Sakai (99%) NP_050570.1
Stx1 converting phage (99%) BAC77866.1
Stx2-converting phage 86 (96%) BAF34067.1
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Page 9 of 14genes in Stx phage genomes is very important in that
context.
Methods
Bacterial strains and culture
The E. coli K-12 strain, MC1061, was used as the bac-
terial host for the production of lysogens. MC1061
(F24B) refers to the F24B lysogen of MC1061; naïve
MC1061 refers to cells that have not been infected by
F24B. E. coli K-12 strain DM1187 was used as the indi-
cator host strain in plaque assay experiments [18].
BL21-AI cells (Invitrogen, Paisley, U.K.) were used as
the expression host for genetic constructs. Bacterial
strains, plasmids and phages used in this study are listed
in Table 4.
All cultures, unless otherwise stated, were propagated
from an overnight (~16 h) starter culture (0.5% v/v
inoculum) in Luria Bertani (LB) broth (Merck KGaA,
Darmstadt, Germany) containing 0.01 M CaCl2,i n c u -
bated at 37°C with shaking at 200 r.p.m. Lysogen cul-
tures were grown in the presence of kanamycin (Kan, 50
μgm l
-1). Induction of protein expression in BL21-AI
cells took place in BHI broth with 0.2% arabinose and 1
mM IPTG.
Induction of phage lysogens
Cultures of MC1061(F24B) cells were incubated with
norfloxacin (1 μgm L
-1) for 1 h at 37°C with shaking at
200 r.p.m. Cultures were then diluted 1:10 in fresh LB
and the bacteria allowed to recover from the growth
inhibitory effects of the antibiotic for 1 h at 37°C (the
recovery period), with shaking at 200 r.p.m.
Antisera production for use in CMAT
A 2 L culture of MC1061(F24B) was propagated for 6
hours. The cells were pelleted and resuspended in 1 ml
of retained supernatant plus 1 ml of LB broth. Protease
inhibitors (20 μL) (Roche Complete Mini EDTA Free
protease inhibitor cocktail tablets, Bath, U.K.) and 10 μL
of lysis buffer (7 M urea, 2 M thiourea, 2% CHAPS, 1%
DTT, Roche Complete Mini EDTA-free protease inhibi-
tor cocktail tablets) were added to each. The samples
were sonicated at 15-18 μ for 6 × 10 s bursts. Absolute
methanol (1.5 ml) was added, and the samples were
incubated at -20°C for 60 min. Protein was harvested by
centrifugation at 16,000 g for 5 min, and the resultant
protein pellets were air-dried and suspended in 0.5 ml
phosphate buffered saline (PBS). The samples were
pooled; the protein content was measured by Bradford
Assay [46] and adjusted to 1 mg ml
-1. A total of 4 mg
of the lysogen protein was sent to Eurogentec (Seraing,
Belgium) for antisera production in rabbits, using the
Ribi adjuvant system. Two rabbits were immunised with
the protein sample on days 0, 14, 28 and 56 of the pro-
gram. Bleeds were carried out on days 0 (pre-immune
sera), 38, 66 and 87 (final bleed). Pre-immune sera from
the two rabbits used were received and tested for cross-
reactivity by western blot analysis.
CMAT was carried out as per instructions from the
l i c e n s eh o l d e r ,O r a g e n i c sI n c . ,F L . ,U . S . A .[ 1 7 , 4 7 ] ,w i t h
the exception that BL21-AI was used as the expression
strain for the phage library. The recommended expres-
sion host, BL21[DE3], is an E. coli-l lysogen, and there-
fore an inappropriate strain to use in phage protein
expression studies [48]. The expression library was cre-
ated from F24B::Kan DNA. The rabbit antisera were
depleted of antibodies reactive to E. coli proteins by a
series of adsorptions to naïve MC1061 whole cells and
cellular lysate, and to BL21-AI + pET30c (empty vector)
whole cells and cellular lysate. The depleted antisera
were compared to undepleted antisera by western blot.
Adsorptions were repeated until no bands were detect-
able by western blot probing of 6 μg of naïve MC1061
proteins.
Peptide expression library construction
Semi-confluent plaque assay plates [18] were overlaid
with 3 ml SM buffer (100 mM NaCl, 8 mM MgSO4, 50
mM Tris-HCl, pH 7.5) and incubated at 4°C for 16 h,
with gentle agitation. The SM buffer and top agar were
transferred to separate 50 ml centrifuge tubes that were
vortexed with 10% (v/v) fresh SM buffer and subjected
to centrifugation at 10,000 g for 10 min. The superna-
tant was pooled and 30 μl of chloroform were added to
each 10 ml of buffer. DNase (5 μgm l
-1)a n dR N a s e( 1
mg ml
-1) were added, and the samples were incubated
at 37°C for 1 h. PEG 8000 (33% [w/v]) was added, and
the samples were incubated on ice for 30 min.
Table 4 Bacterial strains, plasmid and phages used in the study
E.coli strains, plasmids and phages Relevant Genotype Reference
BL21-AI F- ompT hsdSB(rB-, mB-) gal dcm (DE3), arabinose inducible T7 RNA polymerase Invitrogen, Paisley, U.K.
MC1061 F
- Δ(ara-leu)7697 Δ(codB-lacI)3 galK16 l
- mcrA0 rpsL150(strR) mcrB1 [18]
DM1187 F- dam-13::Tn9(Cm
R) dcm- mcrB hsdR-M + gal1 ara- lac- thr- leu- tsxR [45]
TOP10 F- mcrA F80lacZΔM15 recA
+ Invitrogen, Paisley, U.K.
pCR
®-Blunt lacZ a, Kan
R, ccdB Invitrogen, Paisley, U.K.
pET30c Expression vector with T7 promoter, Kan
R, Tet
R, Novagen, Notts, UK
F24B Stx2-phage, ΔstxA2::aph3 [14]
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gation for 10 min at 10,000 g, and the pellets were
resuspended in 500 μl SM buffer per 30 ml starting
volume. Samples were treated with DNase and RNase,
as before. Phage DNA was purified by phenol:chloro-
form:isoamyl alcohol extraction and isopropanol precipi-
tation [49] and resuspended in 100 μl ddH2O. The
F24B DNA (15 μgm l
-1 in TE) was fragmented using a
HydroShear (GeneMachines, MI, USA), at speed code 6
for 30 cycles, followed by 30 cycles at speed code 2.
DNA of the required size range (300-900 bp) was iso-
lated by gel purification. pET30c plasmid (EMD Bios-
ciences) DNA was digested with EcoRVa n d
dephosphorylated with calf intestinal phosphatase (New
England Biolabs) according to the manufacturer’s
recommendations. The size fractionated F24B DNA
fragments were cloned into the prepared pET30c DNA
(50 ng) vector in a molar ratio of 25:1 (insert to vector).
Chemically competent BL21-AI expression host cells
(Invitrogen) were transformed with the plasmid DNA
according to the manufacturer’s recommendations.
Primary screening
Transformed BL21-AI cells were plated onto LBKan
plates and incubated at 37°C (11 h). Nitrocellulose
membrane (0.2 μm pore size, BioTraceTM) was laid
onto the top of each plate for approximately 1 min. The
membranes were transferred colony-side up to LBKan
agar plates supplemented with arabinose (0.2%) and
IPTG (1 mM), and incubated at 37°C for 3 h. The mas-
ter plates were incubated for a further 3 - 5 h at 37°C,
until the colonies reached a diameter of 1-2 mm. The
membranes were lifted from the agar plates and placed
on chloroform-saturated filter paper, colony-side down,
for 1 min, after which the chloroform was allowed to
evaporate completely. The membranes were then gently
agitated in blocking solution (PBS plus 0.5% Tween 20
and 5% skimmed milk powder) for 1 h at ambient tem-
perature, washed in PBST (PBS plus 0.5% Tween 20; 4
× 10 min) with gentle agitation and probed with the pri-
mary antibodies (depleted antisera) in 10 ml PBST
(1:1,250) for 16 h at 4°C with gentle agitation. The
membranes were then washed four times in PBST and
agitated for 1.5 h in secondarya n t i b o d ys o l u t i o n( H R P
conjugated to goat anti-rabbit IgG [Sigma]) (1:30,000).
The membranes were washed four times in PBST,
rinsed twice in PBS and washed for 10 min in PBS,
under gentle agitation. Enhanced chemiluminescent
(ECL) reagent was used to develop the membranes and
the chemiluminescence was visualised by exposure of
Roche Lumi-Film Chemiluminescent Detection Film to
the membranes. Putative positive clones were identified
on the master plates and each one was transferred to
fresh LBKan agar.
PCR verification of insert
For verification of the presence of cloned DNA, putative
positive colonies were used as the template source for a
colony PCR and the T7 promoter and T7 terminator
primers (Novagen, Notts, U.K.). Thermal cycling condi-
tions using Taq polymerase comprised an initial dena-
turation of 5 min at 94°C, 35 cycles of denaturation at
94°C for 30 s, annealing at 55°C for 30 s, extension at
72°C for 30 s kb
-1 product, followed by a final extension
at 72°C for 7 min.
Secondary screening
Putative positive colonies were cultured overnight in
BHI Kan (1 ml), at 37°C, without shaking. The cells
were harvested by centrifugation at 16,000 g. The super-
natant was decanted and the cells resuspended in 20 l
BHI Kan. Each suspension was spotted in triplicate (1
μl) onto duplicate nitrocellulose membranes and placed
on a BHI Kan agar plate. The plates and membranes
were incubated for 3 h at 37°C, the membranes removed
and one of the duplicate membranes overlaid onto a LB
Kan agar plate supplemented with 0.2% arabinose and 1
mM IPTG while the other membrane was placed onto a
LB Kan agar plate. These were incubated for 3 h at 37°
C. The membranes were removed from the plates, and
placed on chloroform- saturated filter paper for 1 min.
Once dry, 1 μl of the lysogen-specific antiserum was
spotted onto the bottom of the membrane, as a positive
control. Antibody reactivity was determined as described
above for primary screening.
DNA sequencing
Plasmid DNA was sequenced by GATC Biotech (Kon-
stanz, Germany), using the T7 promoter and terminator
primers. Sequences were translated using ExPASY’s
Translate tool http://www.expasy.ch/tools/#proteome.
The sequences were aligned to the annotated F24B gen-
ome [GenBank:HM_208303] and CDS in-frame with the
expression vector were documented.
qPCR
Induction of MC1061(F24B) cultures was performed as
described above. A 1 ml sample was taken before addi-
tion of norfloxacin to the cultures, and further 1 ml ali-
quots removed at 10-15 min intervals throughout the 60
min recovery time. RNA was immediately extracted and
DNAse treated with TURBO™ DNAse (Ambion, TX,
USA) according to the manufacturer’s instructions.
Absence of DNA was verified by qPCR. Each RNA sam-
ple (300 ng) was reverse transcribed using random hex-
amer oligonucleotides (Bioline, London, UK). Specific
primers were designed to amplify an approximately 100
bp region of each gene in the study (Additional file 1:
Table S1). qPCR was performed using a StepOnePlus™
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tion consisted of 1 μlo fc D N A ,1xS e n s i M i x Plus SYBR
(Quantace, London, U.K.), 200 nM of specific primers in
a2 5μl reaction. The amplification cycling conditions
were: initial denaturation at 95°C for 10 min; 39 cycles
of denaturation at 95°C for 10 s; annealing at 60°C for
30 s; extension at 72°C for 5 s. A melting curve analysis
was performed for each amplification reaction, with a
temperature gradient of 0.1°C from 55°C to 95°C. No-
template controls and a calibration curve, consisting of
6 dilutions of the PCR amplicon of each gene cloned
into PCR-Blunt vector (Invitrogen, Paisley, U.K.) line-
arised with Nco I (NEB, Herts, U.K.), were included in
every experiment (Additional file 1: Table S1). Statistical
analysis was performed using a one-way ANOVA com-
paring gene copy numbers at different time points in
each experiment to test the hypothesis that there is no
variation in gene copy number during the recovery per-
iod. A post-hoc Dunnett’s test was employed, using the
sample corresponding to the lysogen culture (-60) as the
reference group, to assess whether or not time points
differed from the reference. P < 0.05 values were consid-
ered to be statistically significant.
Protein extraction for 2D-PAGE
Cultures of MC1061 and MC1061(F24B) were incubated
for 6 h at 37°C. Cells were harvested and pellets washed in
1 ml of wash solution (10 mM Tris-HCl, pH 8.0; 1.5 mM
KH2PO4;6 8m MN a C l ;9m MN a H 2 P O 4 ) .C e l l sw e r e
resuspended in 1 ml of resuspension buffer (10 mM Tris-
HCl, pH 8.0; 1.5 mM MgCl2; 10 mM KCl; 0.5 mM DTT;
0.1% SDS; 20 μl of protease inhibitor [Roche Complete-
Mini EDTA Free protease inhibitor cocktail tablets]) and
each sample was sonicated for 5 × 10 s. DNase was added
(5 μgm l
-1) and samples were incubated for 1 h at 37°C.
Samples were centrifuged for 1 h at 12,000 g, the superna-
tant recovered and protein concentration determined
using the Bradford Assay. Aliquots (110 μg protein) of the
sample were taken and precipitated in 10% TCA in acet-
one containing 20 mM DTT for 45 minutes at -20°C. Pel-
lets were washed twice in ether.
2D-PAGE
Isoelectric focussing was carried out on 18 cm IPG
strips (pH 4-7,3-5.6 and 5.3-6.5;GE Healthcare), at 3,500
V for 7 h. Proteins were separated in the second dimen-
sion on 1.5 mm 4% stacking/15% resolving SDS-PAGE
gels, for 6.5 h at 20 W per gel (up to maximum of 180
W). Proteins were silver stained [50].
In-gel digestion of protein samples
This was carried out according to the protocol described
by Courchesne & Patterson [51] with the following
modifications: protein spots were excised from the gel
and destained with 50 μl of destaining solution (30 mM
potassium ferricyanide, 100 mM sodium thiosulphate)
until the silver stain disappeared; protein digestion pro-
ceeded in 25 mM ammonium carbonate/trypsin (5 ng
μl
-1) at 37°C for 16 h.
Matrix-assisted laser desorption/ionisation-time-of-flight
(MALDI-TOF) mass spectrometry
Trypsin-digested protein samples were added to an
alpha-cyano 4-hydroxycinnamic acid matrix (LaserBio-
Labs, France) at a concentration of 10 mg ml
-1 in 50%
ethanol: 50% acetonitrile: 0.1% TFA. Samples were ana-
lysed by MALDI-TOF on an ABI Voyager DE Pro
(MALDI-TOF). The mass spectra generated were pro-
cessed using Data Explorer to clean the spectra and iso-
late monoisotopic peaks (all Applied Biosystems). The
Mascot Peptide Mass Fingerprint Database was used to
search for homologues.
Additional material
Additional file 1: Table S1. PCR amplification primers used in this study.
A compilation of all of the amplification primers used in this study along
with amplification efficiency information.
Additional file 2: Table S2. Significance of Dunnett’s test results for
gene expression data in Figure 3: Results of the Dunnett’s test to
determine significance of gene expression profile differences before and
after prophage induction.
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